A detailed history of Merit Financial Group, LLC transactions in Cerus Corp stock. As of the latest transaction made, Merit Financial Group, LLC holds 11,473 shares of CERS stock, worth $18,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,473
Previous 11,473 -0.0%
Holding current value
$18,586
Previous $18,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$1.16 - $1.6 $13,308 - $18,356
11,473 New
11,473 $18,000
Q1 2025

Apr 09, 2025

BUY
$1.39 - $2.15 $24,529 - $37,941
17,647 New
17,647 $25,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.